Published in HPB (Oxford) on March 21, 2016
Liver function: homogenous or not? HPB (Oxford) (2016) 0.75
Optimal use of hepatobiliary scintigraphy before liver resection. HPB (Oxford) (2016) 0.75
Simplified calculation of body-surface area. N Engl J Med (1987) 11.24
Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg (2002) 8.30
Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg (2000) 5.79
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol (2006) 5.78
Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol (2004) 4.78
Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery (2011) 4.40
One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg (2003) 3.84
The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg (2005) 3.46
Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg (2003) 3.14
Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg (2005) 3.04
Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis. Ann Surg (1987) 2.69
Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg (2007) 2.40
Body surface area and body weight predict total liver volume in Western adults. Liver Transpl (2002) 2.21
Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg (2003) 2.05
Predictive indices of morbidity and mortality after liver resection. Ann Surg (2006) 2.01
Surgical treatment of 109 patients with symptomatic and asymptomatic hepatocellular carcinoma. Surgery (1986) 1.98
Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg (1999) 1.94
Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg (1999) 1.92
Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection. J Gastrointest Surg (2010) 1.81
Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome. Liver Transpl (2004) 1.72
Preoperative assessment of liver function. Surg Clin North Am (2004) 1.67
Hepatectomy: preoperative analysis of hepatic function and postoperative liver failure. Dig Surg (1998) 1.66
Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford) (2010) 1.59
Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg (2005) 1.56
Pattern of recurrence in liver resection for colorectal secondaries. World J Surg (1987) 1.49
Morbidity and mortality after liver resection: results of the patient safety in surgery study. J Am Coll Surg (2007) 1.45
Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study. Ann Surg (2007) 1.42
(99m)Tc-mebrofenin hepatobiliary scintigraphy with SPECT for the assessment of hepatic function and liver functional volume before partial hepatectomy. J Nucl Med (2010) 1.42
Physiological and biochemical basis of clinical liver function tests: a review. Ann Surg (2013) 1.41
Preoperative assessment of postoperative remnant liver function using hepatobiliary scintigraphy. J Nucl Med (2004) 1.40
The small remnant liver after major liver resection: how common and how relevant? Liver Transpl (2003) 1.35
Experimental and clinical studies on the effect of biliary drainage in obstructive jaundice. Am J Surg (1981) 1.34
Risk assessment of posthepatectomy liver failure using hepatobiliary scintigraphy and CT volumetry. J Nucl Med (2007) 1.34
Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl (2006) 1.31
Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer. Br J Cancer (1998) 1.26
Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter. J Am Coll Surg (2002) 1.23
CT- and MRI-based volumetry of resected liver specimen: comparison to intraoperative volume and weight measurements and calculation of conversion factors. Eur J Radiol (2009) 1.23
"State of the art" in liver resection and living donor liver transplantation: a worldwide survey of 100 liver centers. World J Surg (2009) 1.18
Preoperative assessment of liver function: a comparison of 99mTc-Mebrofenin scintigraphy with indocyanine green clearance test. Liver Int (2004) 1.15
Decreased morbidity and mortality rates in surgical patients with hepatocellular carcinoma. Br J Surg (1990) 1.05
Morbidity and mortality after liver resection for benign and malignant hepatobiliary lesions. Liver Int (2008) 1.03
Blood loss and ICG clearance as best prognostic markers of post-hepatectomy liver failure. Hepatogastroenterology (1999) 0.95
Portal vein embolization (prior to major hepatectomy) effects on regeneration, resectability, and outcome. J Surg Oncol (2010) 0.93
Twenty-five-year follow-up for liver resection: the personal series of Dr. Joseph G. Fortner. Ann Surg (2009) 0.93
Analysis of 100 consecutive hepatectomies: risk factors in patients with liver cirrhosis or obstructive jaundice. World J Surg (2001) 0.92
Preoperative liver function assessments to estimate the prognosis and safety of liver resections. Surg Today (2013) 0.89
Mild hepatic steatosis is not a major risk factor for hepatectomy and regenerative power is not impaired. Surgery (2006) 0.89
IODIDA clearance rate: a method for measuring hepatocyte uptake function. Transplant Proc (1992) 0.84
Major compared with limited hepatic resection for hepatocellular carcinoma without underlying cirrhosis: a retrospective analysis. Eur J Surg (1999) 0.82
[Recurrent tumor after R0 resection of colorectal liver metastases. Incidence, resectability and prognosis]. Chirurg (1995) 0.82
Three-dimensional volumetry in 107 normal livers reveals clinically relevant inter-segment variation in size. HPB (Oxford) (2013) 0.78
Hepatic malignancies. Surg Clin North Am (2000) 0.78
[Recent advances in the case management of colorectal cancer liver metastases]. Bull Acad Natl Med (2003) 0.77
A clinical perspective on the criteria for liver resection and the use of liver function tests. World J Surg (2010) 0.76